Skip to content

Retroclavicular Versus Supraclavicular Brachial Plexus Block for Hand and Forearm Surgery

The Efficacy of Retroclavicular Versus Supraclavicular Brachial Plexus Block in Patients Undergoing Forearm and Hand Surgery: a Randomized Controlled Double-blinded Trial.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02641613
Enrollment
120
Registered
2015-12-29
Start date
2016-01-31
Completion date
2018-05-31
Last updated
2018-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand Injury

Brief summary

Patients will be randomized to one of two groups: 1. Supraclavicular group: supraclavicular brachial plexus block performed with the aid of ultrasound; 2. Retroclavicular group: retroclavicular brachial plexus block performed with the aid of ultrasound.

Detailed description

The study will be proposed to all patients undergoing formarm or hand surgery under brachial plexus block. Patients will be randomized to one of two groups The first group - supraclavicular group - will receive an ultrasound-guided brachial plexus block via the supraclavicular approach, by injection of 30 ml of a mixture of ropivacaine 0.5 % + mepivacaine 1 %. The second group - retroclavicular group - will receive an ultrasound-guided brachial plexus block via the retroclavicular approach, by injection of 30 ml of a mixture of ropivacaine 0.5 % + mepivacaine 1 %. Primary outcome is success rate at 30 minutes after the injection defined as loss of sensation to pinprick in the forearm and hand. Secondary outcomes are: needling time, time to first analgesic request, postoperative opioid consumption, pain scores at 12 and 24 hours postoperatively, block-related complications, and patient satisfaction.

Interventions

retroclavicular block for forearm or hand surgery

supraclavicular block for forearm or hand surgery

Sponsors

Hôpital du Valais
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients who undergo forearm or hand surgery under brachial plexus block.

Exclusion criteria

* History of allergic reaction to local anaesthetics * Peripheral neuropathy * Renal or hepatic insufficiency * Coagulation disorders

Design outcomes

Primary

MeasureTime frame
Success rate (loss of sensation to pinprick in the forearm and hand)30 minutes after the injection

Secondary

MeasureTime frameDescription
Time to first analgesic request24 hours
Block-related complications24 hours
Postoperative opioid consumption on postoperative day 124 hours
Needling time in seconds15 min
Pain scores on postoperative day 124 hoursmeasured on a visual analogue scale between 0 and 100
Patient satisfaction as assessed by numerical rating scale24 hoursPatient satisfaction on a scale between 0 (= completely dissatisfied) and 10 (= completely satisfied)
Pain scores at 12 hours postoperatively12 hoursmeasured on a visual analogue scale between 0 and 100

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026